News from tni biotech, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 28, 2014, 09:00 ET

TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card

 TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or the "Company"), a biopharmaceutical company focused on the development, marketing and...

Jul 14, 2014, 15:17 ET

TNI BioTech, Inc. Establishes New Record Date for Spin-Off Stock Dividend of Cytocom, Inc. Shares

 TNI BioTech, Inc. – (OTCQB: TNIB) ("TNIB" or the "Company"), a biotechnology company focused on developing innovative, targeted immune...

Jun 25, 2014, 11:17 ET

TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa - CORRECTION

 TNI BioTech, Inc. (OTC-TNIB) ("TNI BioTech") earlier today announced that its pharmaceutical sales division, Airmed Biopharma Limited,...

Jun 25, 2014, 08:35 ET

TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa

 TNI BioTech, Inc. (OTC-TNIB) ("TNI BioTech") is pleased to announce that its pharmaceutical sales division, Airmed Biopharma Limited,...

Jun 24, 2014, 08:00 ET

TNI BioTech, Inc. Cancels Proposed Reverse Split of its Common Stock

 TNI BioTech, Inc. (OTC: TNIB) ("TNI" or the "Company") a biotechnology company pioneering the development of innovative therapies for...

Jun 18, 2014, 08:00 ET

TNI BioTech, Inc. Files Schedule 14A and Announces Annual Meeting

TNI BioTech, Inc. (OTC: TNIB) ("TNI" or the "Company") announced today that it will hold its 2014 Annual Meeting ("Annual Meeting") of Stockholders...

May 06, 2014, 10:00 ET

TNI BioTech, Inc. Obtains Drug Approval For Sale of Low Dose Naltrexone (LDN) From Government of Malawi

 TNI BioTech, Inc. (OTCQB: TNIB) ("TNI BioTech"), a biotechnology company focused on the development, marketing and distribution of...

May 01, 2014, 10:00 ET

TNI BioTech, Inc. Announces Proposed Spin-Off of Cytocom, Inc.

 TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or the "Company"), a biopharmaceutical company focused on the development, marketing and distribution...

Mar 26, 2014, 10:00 ET

TNI BioTech, Inc. Announces Further Agreement on Methionine-Enkephalin with Hubei Qianjiang Pharmaceutical Co., Ltd.

 TNI BioTech, Inc. (OTC: TNIB), today announced that it has signed a 'Supplementary Cooperation Agreement (the "Agreement") on New Drug...

Mar 12, 2014, 10:00 ET

TNI BioTech, Inc. Granted Additional Patent for Methods for Inducing Sustained Immune Response of T-Cells

 TNI BioTech, Inc. (OTC: TNIB), a biotech company working to combat chronic, life-threatening diseases through the activation and modulation of...

Mar 07, 2014, 10:00 ET

The Brewer Group Announces Strategic Partnership with TNI BioTech, Inc.

The Brewer Group, Inc. ("TBG") a global investment advisory firm, today announced a new strategic partnership with TNI BioTech, Inc. ("TNIB")...

Mar 06, 2014, 10:00 ET

TNI BioTech, Inc. Forms New Subsidiary, Cytocom Inc., to develop LDN and MENK

 TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose...

Feb 11, 2014, 15:30 ET

TNI BIOTECH Announces SEC Clearance Of Form 10 Registration Statement And Clears Way To Upgrade To A Higher Exchange

 TNI BioTech Inc.,  (OTCQB:TNIB) a biotechnology company pioneering the development of
innovative therapies for autoimmune diseases...

Jun 07, 2013, 12:34 ET

TNI BioTech, Inc. Announces Mandatory Exchange of Common Stock Certificates CUSIP Number 872608104 for New Stock Certificates with Active CUSIP 872608203

TNI BioTech, Inc. (TNIB, the "Company") (OTCQB: TNIB) announced today that effective as of the opening of business on Monday June 10, 2013, the...

Jun 03, 2013, 08:00 ET

TNI BioTech, Inc. Announces Death of Senior Vice President and Chief Medical Officer, Dr. Ronald Herberman

 TNI BioTech, Inc. (OTCQB: TNIB) announced today that Dr. Ronald Herberman, the Company's Senior Vice President and Chief Medical Officer,...

May 20, 2013, 08:15 ET

TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace

 TNI BioTech, Inc. (OTCQB: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's...

May 16, 2013, 08:15 ET

TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events

 TNI BioTech, Inc.,  (OTC PINK: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's...

Apr 30, 2013, 08:00 ET

TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant

 TNI BioTech, Inc. (OTC PINK: TNIB) announced today the appointment of industry veteran, Dr. Joseph M. Fortunak, as a strategic consultant to...

Apr 25, 2013, 08:48 ET

TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor

 TNI BioTech, Inc. (OTC PINK: TNIB) is pleased to announce that they have named Terry Lierman from the Summit Global Ventures as a strategic...

Apr 22, 2013, 12:58 ET

TNI BioTech Files Form 10 with SEC

 TNI BioTech, Inc. (OTC Pink: TNIB) (www.tnibiotech.com), announced it has filed its Form 10 to become a fully reporting public company with...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge